These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 10359732)
1. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Bobik A; Agrotis A; Kanellakis P; Dilley R; Krushinsky A; Smirnov V; Tararak E; Condron M; Kostolias G Circulation; 1999 Jun; 99(22):2883-91. PubMed ID: 10359732 [TBL] [Abstract][Full Text] [Related]
2. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010 [TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856 [TBL] [Abstract][Full Text] [Related]
5. TGF-betas and TGF-beta receptors in atherosclerosis. McCaffrey TA Cytokine Growth Factor Rev; 2000; 11(1-2):103-14. PubMed ID: 10708958 [TBL] [Abstract][Full Text] [Related]
6. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury. Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216 [TBL] [Abstract][Full Text] [Related]
8. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms. Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364 [TBL] [Abstract][Full Text] [Related]
9. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors. Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis. Khalil N; Parekh TV; O'Connor RN; Gold LI Exp Lung Res; 2002; 28(3):233-50. PubMed ID: 11936776 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma. Anderson M; Muro-Cacho C; Cordero J; Livingston S; Muñoz-Antonia T Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207 [TBL] [Abstract][Full Text] [Related]
14. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro. Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632 [TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor-beta superfamily receptors in rat eyes. Obata H; Kaji Y; Yamada H; Kato M; Tsuru T; Yamashita H Acta Ophthalmol Scand; 1999 Apr; 77(2):151-6. PubMed ID: 10321529 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma. Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800 [TBL] [Abstract][Full Text] [Related]
17. Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. Piao M; Tokunaga O J Atheroscler Thromb; 2006 Apr; 13(2):82-9. PubMed ID: 16733295 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta2, but not beta1 and beta3, is critical for early rat lung branching. Liu J; Tseu I; Wang J; Tanswell K; Post M Dev Dyn; 2000 Apr; 217(4):343-60. PubMed ID: 10767079 [TBL] [Abstract][Full Text] [Related]
19. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Qu R; Silver MM; Letarte M Cell Tissue Res; 1998 May; 292(2):333-43. PubMed ID: 9560476 [TBL] [Abstract][Full Text] [Related]
20. The expression of matrix metalloproteinases-9, transforming growth factor-beta1 and transforming growth factor-beta receptor I in human atherosclerotic plaque and their relationship with plaque stability. Jiang X; Zeng HS; Guo Y; Zhou ZB; Tang BS; Li FK Chin Med J (Engl); 2004 Dec; 117(12):1825-9. PubMed ID: 15603712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]